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Consequences of oxidative stress may be beneficial or detrimental in physiological
systems. An organ system’s position on the “hormetic curve” is governed by the source
and temporality of reactive oxygen species (ROS) production, proximity of ROS to moieties
most susceptible to damage, and the capacity of the endogenous cellular ROS scavenging
mechanisms. Most importantly, the resilience of the tissue (the capacity to recover from
damage) is a decisive factor, and this is reflected in the disparate response to ROS
in cardiac and skeletal muscle. In myocytes, a high oxidative capacity invariably results
in a significant ROS burden which in homeostasis, is rapidly neutralized by the robust
antioxidant network. The up-regulation of key pathways in the antioxidant network is a
central component of the hormetic response to ROS. Despite such adaptations, persistent
oxidative stress over an extended time-frame (e.g., months to years) inevitably leads to
cumulative damages, maladaptation and ultimately the pathogenesis of chronic diseases.
Indeed, persistent oxidative stress in heart and skeletal muscle has been repeatedly
demonstrated to have causal roles in the etiology of heart disease and insulin resistance,
respectively. Deciphering the mechanisms that underlie the divergence between adaptive
and maladaptive responses to oxidative stress remains an active area of research for
basic scientists and clinicians alike, as this would undoubtedly lead to novel therapeutic
approaches. Here, we provide an overview of major types of ROS in striated muscle
and the divergent adaptations that occur in response to them. Emphasis is placed on
highlighting newly uncovered areas of research on this topic, with particular focus on the
mitochondria, and the diverging roles that ROS play in muscle health (e.g., exercise or
preconditioning) and disease (e.g., cardiomyopathy, ischemia, metabolic syndrome).
Keywords: hormesis, carbonyl stress, mitochondria, lipid peroxidation, redox environment, adaptation, heart,
skeletal muscle
INTRODUCTION
A fairy tale emerged in England during the first half of the nine-
teenth century, telling the story of how a meddlesome little girl
named Goldilocks discovered the forest home of a family of bears.
In this classic tale, the reader will remember that during her
exploration of the bears’ home, Goldilocks determined that baby
bear’s porridge was “not too hot, not too cold,” and his bed was
“not too hard, not too soft.” In essence, they were “just right.”
Such is the nature of homeostasis in our organ systems, in that
stress in either one direction or another can tip the scales toward
disease, or maladaptation, thereby disrupting homeostasis. It is
in this context that the redox environment of a cell is main-
tained within a “Goldilocks Zone,” whereby ROS production is
sufficiently counterbalanced by the antioxidant capacity/quality
control systems, and the environment is optimal for homeostasis.
However, when faced with persistent or uncompensated oxidative
stress, the redox environment can be pushed outside of this
Goldilocks Zone, where cell death, inflammation and disease
ensues. The schematic shown in Figure 1A illustrates this concept
of the Goldilocks Zone in redox balance, and uses two con-
trasting stressors that are common to the cardiovascular system,
cardio-metabolic disease and exercise, as examples. Both exercise
and disease generate oxidative stress in striated muscle. However,
the persistent and uncompensated oxidative stress resulting from
cardio-metabolic disease ultimately pushes the myocytes outside
the Goldilocks Zone, while the pulsatile, compensated oxidative
stress that follows successive bouts of exercise keeps the myocytes
in the Zone, and in good health.
High metabolic demand in striated muscle necessitates a far
greater degree of arterial blood perfusion and oxygen tension
than virtually any other tissue in the body. The natural conse-
quence of this high availability and concentration of oxygen is
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FIGURE 1 | Oxidative stress adaptations in striated muscle and the
Goldilocks Zone. The concept of the Goldilocks Zone in the redox
environment of striated muscle is illustrated in the schematics shown above.
Time-dependent changes in tissue oxidative stress due to exercise (green line)
is pulsatile in nature, coming from consecutive bouts of exercise over time,
whereas the oxidative stress arising from cardio-metabolic diseases (red line)
is persistent. As depicted in (A), the ultimate outcome of these two stressors
is divergent, since exercise-induced ROS over time keeps the myocytes well
within the Goldilocks Zone of homeostasis (region between the Reducing and
Oxidative stress, two dashed black lines), while disease-induced ROS
eventually pushes the myocytes outside of the Zone, leading to deleterious
consequences (e.g., unresolved inflammation, electro-mechanical dysfunction,
mitochondrial dysfunction and cell death). These divergent outcomes are best
explained by the adaptive responses in the antioxidant capacity and cell quality
control mechanisms that are elicited by these two sources of oxidative stress.
(B) Illustrates this adaptive response, in that exercise-induced ROS leads to
augmentation of the antioxidant capacity and protection against exogenous
stressors over time. Conversely, disease-induced ROS, due to its persistent
and insidious nature, ultimately overwhelms endogenous protective
mechanisms, ultimately resulting in a maladaptive response.
a greater burden placed upon endogenous antioxidant systems
to buffer the ROS that are invariably produced as a bi-product.
Numerous enzymatic and non-enzymatic sources of ROS exist in
skeletal muscle and heart, and it is only through the work of these
important antioxidant networks that the cellular redox environ-
ment is maintained within a range that is optimal for homeostasis
and proper electro-mechanical function. ROS production in stri-
ated muscle is persistent in nature, therefore, oxidative stress in
this tissue should be viewed in the context of a continuum in
that there is always a degree of oxidative stress present, and it
only becomes deleterious under certain contexts (i.e., persistence,
compartmentalization or lack of adaptive responses). In fact,
recent work in transgenic mice has documented that the removal
of NADPH oxidase (NOX) in the heart, and the subsequent pres-
ence of overwhelming reductive stress, can lead to exacerbation of
ischemia/reperfusion injury (Matsushima et al., 2013). A similar
phenomenon is observed in skeletal muscle, where overexpres-
sion of the antioxidant enzyme glutathione peroxidase-1 (GPx1)
in mice was shown to cause insulin resistance (McClung et al.,
2004). These paradoxical findings embody the “not too hot, not
too cold” concept of the Goldilocks Zone in redox balance, and
also underscore both the complexity and importance of the redox
environment to homeostasis. Further, they are evidence of the
need for a more rigorous investigation of the mechanisms by
which the redox environment of striated muscle adapts to various
metabolic challenges.
This paradox between “good” and “bad” oxidative stress is
best exemplified in the contrasting effects of the increased ROS
that is well-known to occur in striated muscle with exercise,
compared to the increased ROS from cardio-metabolic diseases
characterized by metabolic supply/demand mismatch, such as
nutrient overload (i.e., obesity, high fat/high sugar diets, dia-
betes) and ischemia. Shown in Figure 1B is a schematic depicting
how disease-induced ROS and exercise-induced ROS lead to
divergent outcomes in striated muscle. Both cardio-metabolic
disease and exercise cause increases in ROS, but they differ in
their substance and temporality. The ROS produced from suc-
cessive bouts of exercise is pulsatile in nature, with periods of
recovery in between (green line Figure 1B). Indeed, increased
ROS occurs in skeletal muscle and heart during exercise from
a variety of sources, but the broad outcome of this oxidative
stress is beneficial, resulting in the induction of mitochon-
drial biogenesis and aerobic capacity, augmented antioxidant
capacity, improved vascularization, and insulin sensitivity. The
beneficial ROS-mediated adaptations to exercise have been the
topic of many thorough reviews (Powers and Jackson, 2008;
Powers et al., 2010, 2011a,b; Gomez-Cabrera et al., 2012). In
many ways the response of striated muscle to exercise-induced
oxidative stress is embodied in the concept of hormesis, in
that the muscle experiences a beneficial, adaptive response to
sub-lethal increases in ROS that occur during and immedi-
ately following each bout of exercise (Ristow and Schmeisser,
2011; Nikolaidis et al., 2012). Conversely, nutrient overload and
ischemia/reperfusion also cause increased ROS in skeletal mus-
cle and heart from numerous sources, particularly mitochon-
dria, but net effects are deleterious, resulting in inflammation
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and recruitment of immune cells, activation of pro-fibrotic gene
expression and cardiac hypertrophy, increased cell death, and
insulin resistance (reviewed in Fisher-Wellman and Neufer, 2012;
Cavalera et al., 2014; Dai et al., 2014). Some evidence of mod-
est hormesis has been reported in myocardium with nutrient
overload/diabetes (Joyeux-Faure et al., 2006; Tocchetti et al.,
2012; Fisher-Wellman et al., 2013; Rindler et al., 2013; Chen
et al., 2014; Lejay et al., 2014), but ultimately these modest
adaptive responses become overwhelmed, and the tissue/organ
succumbs to the deleterious effects over time (red line in
Figure 1B).
The “Goldilocks Zone” of redox balance in muscle scales down
from whole tissue to mitochondrial level. Work by Aon and col-
leagues showed that rates of ROS emission (ROS produced—ROS
scavenged) from mitochondria are substantially elevated when
the mitochondrial redox environment is either highly reduced
(e.g., nutrient overload, diabetes), or highly oxidized (e.g., reper-
fusion) (Aon et al., 2010; Cortassa et al., 2014). This increased
ROS emission observed at both ends of the redox spectrum would
presumably lead to different consequences at cell and tissue level,
as the antioxidant capacity is considerably more compromised
during a highly oxidized state than it is during a highly reduced
state. At the level of cells and tissues, however, there are also
many other considerations such as the temporality of the change
in redox environment (i.e., acute vs. persistent) and the exist-
ing mechanisms of adaptation intrinsic to the cells experiencing
the stress at a given time, all of which would dictate the global
response to increased mitochondrial ROS emission.
In the following sections we provide an overview of this
contrast in outcomes between the “bad” oxidative stress that
occurs in skeletal muscle and heart as a result of diseases asso-
ciated with metabolic supply/demand mismatch (e.g., nutri-
ent overload/obesity, ischemia), and “good” oxidative stress
that occurs in these organs with therapeutic interventions such
as pre-conditioning and exercise. Major sources of ROS and
their byproducts in these conditions will be discussed, along
with potential mechanisms underlying the adaptive, beneficial
responses and the maladaptive, deleterious responses. Emphasis
will be placed on mitochondrial sources of ROS and mitochon-
drial antioxidant networks, as this organelle is recognized as the
primary source, sink, and target of intracellular ROS in mus-
cle. Furthermore, descriptions of lesser-known types of oxidative
stress (e.g., lipid peroxidation and carbonyl stress) and relevant
detoxification systems are another area of special emphasis, as
these are increasingly recognized to be major players in ROS-
mediated adaptation. Where appropriate, clinical and transla-
tional studies will be described.
CARDIO-METABOLIC DISEASE AND OXIDATIVE STRESS IN
STRIATED MUSCLE
Much focus has been directed in recent years toward document-
ing the contribution of ROS “production” to disease etiology,
and toward identifying enzymatic sources of ROS as underly-
ing mechanisms. Such an emphasis toward the “supply-side” of
ROS is important, but can often be short-sighted as it ignores
the vast redox circuits and antioxidant networks that exist within
cells. Indeed, a major source of the problem of oxidative stress
in chronic disease likely involves the inability of the myocytes’
antioxidant networks to adequately compensate for the increase
in ROS production that occurs. Never-the-less, for purposes of
this portion of the review we will focus on major sources of
ROS production within myocytes, since a number of sources have
consistently been shown to be associated with cardio-metabolic
diseases such as obesity, diabetes, myocardial ischemia, and other
chronic diseases. Whether this increased ROS is cause or con-
sequence of these diseases is still not clear, although it appears
likely that it is both. Figure 2 illustrates some of the major sources
of ROS in myocytes which will be discussed in the subsequent
sections, as well as common deleterious responses and adaptive
responses that accompany the ROS. Understanding the mecha-
nisms behind this lack of adaptability, or maladaptive response to
ROS, may be the key to unraveling this paradox of “good vs. bad”
oxidative stress in striated muscle, thereby leading to improve-
ments in existing therapies and identification of novel therapeutic
targets.
MAJOR SOURCES OF ROS PRODUCTION IN STRIATED MUSCLE WITH
CARDIO-METABOLIC DISEASES
Prominent mitochondrial and non-mitochondrial enzymatic sources
of ROS
The cytosol, plasma membrane, nucleus, and peroxisomes are all
sites of ROS production, but for myocytes in particular, the mito-
chondria is widely considered to be the predominant source of
ROS (reviewed in Jezek and Hlavata, 2005). Within the mitochon-
dria, the electron transport system (ETS) has been well-studied
as a source of ROS production with superoxide radicals forming
spontaneously at complexes I, II, and III via the swift addition
of leaking electrons to an incompletely reduced oxygen (St-Pierre
et al., 2002; Kudin et al., 2004; Drose and Brandt, 2012; Siebels
and Drose, 2013). A comprehensive overview of the sites and reg-
ulation of ROS production by the mitochondrial ETS is beyond
the scope of this review, and has been extensively reviewed else-
where (Liu, 1997; Andreyev et al., 2005; Stowe and Camara, 2009).
Although the ETS is unquestionably a major producer of
ROS in myocytes, the enzyme monoamine oxidase (MAO) is
often overlooked as a mitochondrial source of ROS in cardiomy-
ocytes. Tethered to the outer mitochondrial membrane, MAO is
responsible for oxidative deamination of catecholamines, simul-
taneously generating H2O2, NH
+
4 and reactive aldehydes in the
process (Lewinsohn et al., 1978). The two isoforms of the enzyme,
MAO-A and MAO-B, have differing affinities for various sub-
strates and inhibitors, although both isoforms can metabolize
all catecholamines to some extent. MAO-A is selectively inhib-
ited by clorgyline and has been shown to have a significantly
greater capacity to metabolize serotonin and norepinephrine than
MAO-B. MAO-B is selectively inhibited by selegiline and has
a profoundly greater capacity to metabolize phenylethylamine
then MAO-A. Both isoforms contribute relatively equally to
oxidative deamination of dopamine, tyramine, and tryptamine
(Youdim et al., 1988). The predominance of one isoform vs. the
other within the body is tissue-dependent and the levels between
species can also vary significantly (Saura et al., 1996). The heart
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FIGURE 2 | Cell signaling pathways underlying ROS adaptation in
striated muscle. The beneficial and deleterious consequences of oxidative
stress coming from cardio-metabolic diseases (top) or exercise (bottom) in
striated muscle at the subcellular level are shown here. Note the difference in
designation of solid-line arrows for the persistent ROS coming from disease,
compared to dashed-line arrows representing the pulsatile ROS coming from
exercise. Formation of lipid peroxides and their derivative aldehydes such as
4-hydroxynonenal (HNE), along with their subsequent reactivity to cause
protein carbonylation and carbonyl stress is depicted by yellow lightning bolts
in cytosol and mitochondria. (NOX, NADPH oxidase; HFHS, high fat, high
sucrose; PUFA, polyunsaturated fatty acids; FFA, free fatty acids; AA,
arachidonic acid; PLA2, phospholipase A2; PPAR, peroxisome
proliferator-activated receptor; ANT, adenine nucleotide translocase; COX IV,
cytochrome oxidase IV; ATP, adenosine tri-phosphate; Nrf2, NF E2-related
factor 2; NRF1, nuclear respiratory factor 1; GST, glutathione S-transferase;
ALDH2, aldehyde dehydrogenase 2; GCLC, γ-Glutamylcysteine ligase
catalytic subunit; GPx, glutathione peroxidase; NQO-1, NADPH-quinone
oxido-reductase-1; GR, glutathione reductase; GSHt, total glutathione; Trx,
thioredoxin; TxnRd2, thioredoxin reductase-2; MAO, monoamine oxidase;
MnSOD, manganese superoxide dismutase; CAT, catalase).
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contains a mix of both isozymes corresponding to its metabolic
needs, much of which is a result of the continuous exposure to
dopamine and norepinephrine from nerve terminals and circulat-
ing epinephrine from the adrenal glands (Kaludercic et al., 2011,
2014). A recent study completed in our laboratory showed that
MAO activity is highly variable between individuals and that it is a
major generator of ROS in human atrial myocardium (Anderson
et al., 2014a).
MAO has both direct and indirect ROS-producing capacity.
It has been shown that in isolated brain mitochondria, MAO
directly generates a 48-fold greater rate of H2O2 than the ETS
(Hauptmann et al., 1996). The H2O2 produced is converted
into water and molecular oxygen by peroxidases, and the alde-
hyde metabolite produced is efficiently converted by aldehyde
dehydrogenase (ALDH) into its respective carboxylic acid. In
mitochondria, ALDH2 has been shown to be responsible for
converting the highly reactive aldehyde metabolites of dopamine
oxidation (3,4-dihydroxyphenylacetaldehyde, DOPAL), and sero-
tonin (5-hydroxyindole-3-acetaldehyde, 5-HIAL) into their cor-
responding acetates (Ambroziak and Pietruszko, 1991; Rooke
et al., 2000). When MAO activity is high, a surge in catecholamine
levels would be expected to cause greater ROS production from
the ETS, suppressed ATP production, insufficient calcium han-
dling, and mitochondrial DNA damage due to formation of these
reactive byproducts if there is not an appropriate antioxidant
buffering capacity present.
In addition to mitochondrial sources, the enzyme NADPH
oxidase (NOX) is a major producer of ROS in striated muscle.
NOX enzyme expression has been documented in the heart at
various stages of development, with NOX4 isoform predominat-
ing in early developmental stage (Li et al., 2006), and NOX2 in
the adult heart (Ambroziak and Pietruszko, 1991). Sakellariou
and co-workers recently showed that NOX activity constituted
the bulk of ROS production in skeletal myofibers at rest and dur-
ing contraction, corresponding to expression of NOX2 and NOX4
isoforms in this tissue (Sakellariou et al., 2013).
Lipid peroxidation—A unique and important ROS
The mitochondrial membranes contain a high density of polyun-
saturated fatty acids (PUFAs) and phospholipids which are sus-
ceptible to peroxidation (Bacot et al., 2003; Osman et al., 2011).
Phosphatidylethanolamine and phosphatidylcholine are the most
abundant phospholipids and comprise ∼40% and ∼30% of
total mitochondrial phospholipids, respectively. Cardiolipin and
phosphatidylinositol (PI) account for ∼10–15% of phospho-
lipids, whereas phosphatidic acid (PA) and phosphatidylserine
(PS) comprise ∼5% of the total mitochondrial phospholipids.
Cardiolipin is concentrated in the inner mitochondrial mem-
brane in close proximity to the ETS. Although it comprises a
relatively a low percentage of total membrane phospholipid, its
peroxidation is directly associated with a decline in activity of res-
piratory complexes III and IV, and the release of cytochrome c
which initiates apoptotic signaling (Fry and Green, 1981; Paradies
et al., 1999; Chicco and Sparagna, 2007). This is significant
because cardiolipin is especially susceptible to peroxidation.
Upon formation, lipid peroxides either propagate to form
more lipid peroxides, or spontaneously degenerate to form more
stable lipid peroxide products (LPPs) (Bridges et al., 1983;
Esterbauer et al., 1991). The final LPP formed is dependent on the
initial fatty acid oxidized. One particularly reactive LPP formed
via peroxidation of n-6 PUFAs such as arachidonic acid (AA,
illustrated in Figure 2) is the aldehyde 4-Hydroxynonenal (HNE).
This is particularly relevant because the Western diet contains
a high ratio of n-6 to n-3 PUFAs, ∼10:1 by some estimates
(Guichardant et al., 2004; Cordain et al., 2005). HNE is relatively
stable, electrophilic and lipophilic thus is capable of travers-
ing across cellular compartments. Approximately 2–8% of HNE
formed reacts with proteins as well as DNA- guanine residues to
form HNE-adducts (Nair et al., 1999; Siems and Grune, 2003;
Blair, 2008; LoPachin et al., 2009; Minko et al., 2009; Maier et al.,
2010; Chavez et al., 2011).
DELETERIOUS (i.e., MALADAPTIVE) CONSEQUENCES OF PERSISTENT
OXIDATIVE STRESS WITH CARDIO-METABOLIC DISEASES
The presence of a persistent sub-lethal oxidative stress in striated
muscle has been associated with a variety of cardio-metabolic
diseases for many years. Recent studies have uncovered poten-
tial roles for oxidative stress as causal factors underlying these
diseases, although extracting clearly defined roles for disease
causality vs. simple association remains a challenge. Due to its
primary function in regulating cellular metabolism and oxygen
consumption, the mitochondrial ETS is known to increase ROS
production in striated muscle with a wide variety of diseases
involving metabolic supply-demand mismatch. In experimen-
tal and clinical models of obesity/type 2 diabetes (O/T2D), an
increase in ROS production from mitochondrial ETS has been
reported in both heart (Boudina and Abel, 2007; Anderson et al.,
2009, 2012; Boudina et al., 2009) and skeletal muscle. During
ischemia, mitochondrial ROS is increased from several sites,
largely a result of oxidative damage to ETS and to enzymes
in the matrix such as aconitase. Upon reperfusion following
ischemia, a burst of ROS from the ETS is a well-characterized
phenomenon that has been implicated to be both beneficial under
some contexts (e.g., pre-conditioning, see next section), or delete-
rious. Comprehensive reviews of current knowledge regarding the
sources and consequences of mitochondrial ROS during ischemia
and reperfusion in striated muscle can be found elsewhere (Tullio
et al., 2013; Chen et al., 2014; Lejay et al., 2014).
MAO’s unique orientation relative to the ETC provides the
ability for MAO to interfere with mitochondrial function and cel-
lular energetics, although very little is known about the potential
contribution of MAO-derived ROS in cardio-metabolic dis-
eases. One study reported that MAO-derived ROS led to dimin-
ished state 3 and state 5 respiration (Cohen and Kesler, 1999).
Furthermore, Hauptmann and colleagues showed that MAO-
derived H2O2 can introduce mutations in mitochondrial DNA
(mtDNA). Their results demonstrated that H2O2, produced from
MAO exposure to tyramine, can readily diffuse through the inner
mitochondrial membrane and produce a significant increase in
mtDNA single strand breaks (Hauptmann et al., 1996). Because
of MAO’s proximity to the mitochondrial oxidative phosphory-
lation system, ROS produced by MAO could conceivably disrupt
the ATP-dependent electrochemical and contractile functions of
cardiomyocytes, given the heavy reliance on mitochondria for
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ATP in these cells (Berman and Hastings, 1999; Kaludercic et al.,
2011).
In addition to altering mitochondrial energetics, the byprod-
ucts of MAO deamination can wreak havoc on the cell by
stimulating apoptotic and hypertrophic pathways, and further-
more may trigger other sites within the cell to release ROS.
In myocardium, MAO-derived H2O2 at low levels can stimu-
late hypertrophic and fibroblast proliferative pathways, including
ERK1/2 (Sabri et al., 1998) and NFAT 3/4 (Kaludercic et al., 2010)
while higher levels lead to apoptotic and necrotic pathways via
Bax up-regulation (Bianchi et al., 2005). Aldehyde metabolites
may initiate lipid peroxidation which can increase levels of 4-HNE
(Kaludercic et al., 2010), inactivate proteasomes (Farout and
Friguet, 2006) and the ETS (Choksi et al., 2004) as well. Recent
studies have specifically investigated the role of MAO and ROS
production in the etiology of cardiac disease since cardiomyocytes
are constantly exposed to catecholamines in vivo. Kaludercic and
colleagues studied the role of MAO-derived ROS in the devel-
opment of cardiac hypertrophy induced with pressure overload
through transverse aortic constriction (TAC). The results of these
studies showed that compared to MAO-B null mice, wild-type
mice showed a significantly greater increase in left ventricle size,
decreased fractional shortening, and increased levels of HNE and
fibrosis following TAC, signifying higher ROS formation and
lipid peroxidation due to MAO activity (Kaludercic et al., 2014).
Similarly, studies in a mouse model of diabetes revealed that
MAO-A activity and mitochondrial mass in hearts of diabetic
mice were higher than in normo-glycemic mice. The researchers
hypothesized that insulin resistance had led to the diminished
antioxidant capacity of the cell, in turn leading to more suscep-
tibility to MAO-derived ROS, further illustrating the connection
between nutrient overload and diminished antioxidant capacity
(Mellor et al., 2010; Manni et al., 2013).
The pathophysiologic involvement of ROS derived from NOX
activity in striated muscle remains an area of active investiga-
tion. NOX-derived ROS has been shown to be increased and
associated with mitochondrial dysfunction and insulin resistance
in both heart (Vazquez-Medina et al., 2013) and skeletal mus-
cle (Yokota et al., 2009) of obese rodent models. Other reports
clearly implicate myocardial NOX involvement in the develop-
ment of cardiac hypertrophy and fibrosis in O/T2D (Yamamoto
et al., 2008; Fukuda et al., 2010), pressure overload and heart
failure (Bendall et al., 2002; Byrne et al., 2003; Heymes et al.,
2003; Johar et al., 2006). With myocardial ischemia, however, the
role of NOX-derived ROS is ambiguous. Despite evidence that
NOX expression and activity is induced in experimental (Meischl
et al., 2006) and clinical studies (Krijnen et al., 2003) of myocar-
dial ischemia, myocardial NOX2- and p47PHOX-deficient mice
exhibit no changes in infarct size compared to wild-type following
ischemia/reperfusion injury (Hoffmeyer et al., 2000; Frantz et al.,
2006). Recent studies have shed some light on these disparate
findings. An intriguing study by Matsushima and co-workers
showed that myocardial infarct size/area at risk was substan-
tially higher in mice when both systemic NOX2 and myocardial
NOX4 was absent, and they attributed this to a downregulation
of adaptive response pathways mediated by hypoxia-inducible
factor-1α (HIF1α) in the hearts of these double-knockout mice
(Matsushima et al., 2013). Another recent study provided very
compelling evidence that NOX4 activity is absolutely necessary
for maintaining optimal cardiac redox environment under nor-
moxic conditions, and that eliminating cardiac NOX4 promoted
reductive stress and exacerbated ischemia/reperfusion injury in
mice (Yu et al., 2014). These studies, and others, illustrate the
highly complex roles for NOX in the heart, demanding that
further investigation of ROS production is necessary to under-
stand the extent to which perturbations of the redox environment
underlie cardio-metabolic diseases.
Until recently, LPPs have been viewed as mere bi- products and
bio-markers of oxidative stress (Gutteridge, 1995; Niki, 2009).
A rapidly growing body of scientific literature now places LPPs
at the front of pathophysiology for a large number of diseases
involving striated muscle. In a toxicological study of neonatal car-
diomyocytes, HNE caused apoptosis associated with a decrease
in GSH, a surge in intracellular Ca2+ levels and a loss of mito-
chondrial membrane potential (Hortigon-Vinagre and Henao,
2014). In skeletal muscle of the diaphragm, protein carbony-
lation derived from LPPs has been shown to be increased in
sepsis, mechanical ventilation and COPD and this contributed
to muscle contractile dysfunction in these conditions (Barreiro,
2014).
Several groups have reported increased lipid peroxidation and
carbonyl stress in the cardiovascular system of diabetic patients
(Arzamastseva et al., 2007; Anderson et al., 2009; Annadurai
et al., 2014). Studies in diabetic rat heart show that HNE binds
preferentially to cysteine > histidine > lysine residues in the mito-
chondria (LoPachin et al., 2009). Residues that become modified
in this way are often found in the active-site of enzymes, and
also in structural motifs responsible for maintaining tertiary and
quaternary structure (Korotchkina et al., 2001; Levonen et al.,
2004). Mitochondrial protein modification by HNE corresponds
to reduced enzyme activity for key enzymes such as adenine
nucleotide translocase (ANT), succinate dehydrogenase and α-
ketoglutarate dehydrogase in the hearts of diabetic rats (Chen
et al., 1995, 2001; Benderdour et al., 2003; Nguyen and Picklo,
2003; Lashin et al., 2006; Chavez et al., 2011). HNE modification
of mitochondrial enzymes is represented by yellow lightning bolts
shown in Figure 2.
COMPENSATORY MECHANISMS FOR ADAPTATION TO LPPs AND
CARBONYL STRESS
One of the exquisite features of striated muscle, particularly
the heart, is that it is very plastic and can adapt to a broad
array of stressors. Carbonyl stress arising from PUFA peroxi-
dation is known to activate genes involved in phase I and II
antioxidant/detoxification, mitochondrial biogenesis, and other
pathways, all of which serve to restrain the further production
of PUFA-derived aldehydes and suppress their toxic effects. A
primary adaptive response pathway that is activated by oxida-
tive and carbonyl stress involves NF E2-related factor-2 (Nrf2).
Electrophiles such as LPPs and PUFA-derived aldehydes gener-
ated during periods of oxidative stress activate Nrf2 by liberating
it from its tethering protein Keap1 in the cytosol, allowing it
to translocate to the nucleus where it binds to antioxidant/anti-
inflammatory response elements (AREs) in promoter regions
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of genes/proteins involved in glutathione synthesis and phase
II detoxification (Motohashi and Yamamoto, 2004). Studies
have shown that HNE induces nuclear accumulation of Nrf2
and up-regulates many GSH-synthesizing enzymes and proteins
(reviewed in Chapple et al., 2013). Indeed, pre-conditioning
of the heart by retro-orbital injection of HNE induces cardio-
protection from ischemia/reperfusion injury via Nrf2, and this
cardioprotection is lost in Nrf2−/− mice (Zhang et al., 2010).
The roles and regulation of Nrf2, and other transcription factors
that activate the ARE, is well beyond the scope of this review,
and the reader is referred to other excellent review articles on
this topic (Sykiotis and Bohmann, 2010; Tkachev et al., 2011;
Chartoumpekis and Kensler, 2013).
In addition to Nrf2, recent evidence has implicated mem-
bers of the peroxisome proliferator activated receptor (PPAR)
family in the cellular response to ROS. Several reports have
documented a key role for PPARα and PPARγ in augment-
ing the antioxidant capacity of liver (Toyama et al., 2004;
Abdelmegeed et al., 2009; Guelzim et al., 2011) and vascular
tissue (Inoue et al., 2001a,b) in response to oxidized PUFAs.
Our group recently completed a small clinical trial and observed
that a concentrated dose of fish oil n-3 PUFA’s was associated
with up-regulation of several antioxidant enzymes, particularly
mitochondrial-localized thioredoxin reductase-2 (TxnRd2), and
this was accompanied by increased nuclear transactivation of
PPARγ, in atrial myocardium of patients undergoing cardiac
surgery (Anderson et al., 2014b). This finding is particularly
intriguing given the emerging evidence that TxnRd2 is critical for
maintaining mitochondrial redox balance in multiple cell types
and tissues, including the heart (Rigobello et al., 2005; Stanley
et al., 2011; Fisher-Wellman et al., 2013). These articles and other
recent literature documenting the beneficial adaptations to ROS
in striated muscle under various physiological contexts are listed
in Table 1.
Another key adaptive response to ROS includes activation of
cellular quality control pathways in myocytes, namely autophagy
and mitophagy. These pathways are a very active and rapidly
expanding area of research, and well beyond the scope of this
review. The role of autophagosome formation in the adaptive
response to ROS in myocytes are shown in Figure 2 and is the
topic of a number of thorough reviews (Gurusamy and Das, 2009;
Lee et al., 2012c; Rahman et al., 2014).
LPP detoxification occurs at two main stages. The first is at
the site of lipid peroxidation itself (membrane-localized), and the
second is in the cytosol. Following their formation, LPPs may
undergo phase I biotransformation where they are conjugated
to antioxidant molecules (i.e., glutathione). Alternatively, LPPs
are converted by phase II detoxification enzymes such as alde-
hyde dehydrogenase (Budas et al., 2009), which converts LPPs to
their corresponding alcohols. Below we discuss some of the major
enzymes involves in the detoxification of LPP-derived aldehydes.
It is important to note for many of these enzymes, their enzy-
matic efficiency is itself decreased by aldehydes which may be key
factor in the limitation of antioxidant capacity. A list of the major
enzymes responsible for detoxifying LPPs, along with the reaction
catalyzed by the enzyme, can be viewed in Box 1.
Glutathione-dependent enzymes
Glutathione peroxidase 4. GPX4 is a member of the glu-
tathione peroxide family of selenoenzymes enzymes. In addi-
tion to being able to neutralize small hydroperoxides such as
H2O2, it is one of only a few enzymes capable of neutralizing
complex and bulky hydroperoxides (e.g., cholesterol hydroperox-
ides) (Brigelius-Flohe, 1999; Imai et al., 2003; Yant et al., 2003;
Brigelius-Flohe and Maiorino, 2012). GPX4 is unique in that
Box 1 | Mechanism of LPP clearance by different enzyme
systems.
Glutathione dependent enzymes
1. Glutathione Peroxidase 4
 ROOH+ 2GSH→GSSG+ROH+H2O




 RCHO+NAD++H2O→RCOOH+NADH + H+
Molybdenum hydroxylases
4. Aldehyde oxidase (Pryde et al., 2010)
 aldehyde + H2O + O2 → a carboxylic acid + H2O2
5. Xanthine Oxidase
 Xanthine + H2O + NAD+←===→ urate + NADH
 Hypoxanthine+H2O+NAD+←===→ xanthine+NADH
 Xanthine + H2O + O2←===→ urate + H2O2
Aldehyde reducing enzymes





Table 1 | Recent literature illustrating beneficial adaptations to ROS in striated muscle.
Muscle Physiological state/disease References
Myocardium Ischemia/reperfusion Kevin et al., 2003a; Dost et al., 2008; Liu et al., 2008; Zhang et al., 2010; Penna et al., 2013; Tullio
et al., 2013; Kalogeris et al., 2014
Myocardium Exercise Akita et al., 2007; Sanchez et al., 2008; Nelson et al., 2011; Frasier et al., 2013; Fittipaldi et al., 2014
Myocardium Nutrient overload Joyeux-Faure et al., 2006; Anderson et al., 2012; Tocchetti et al., 2012; Fisher-Wellman et al., 2013;
Rindler et al., 2013; Chen et al., 2014; Lejay et al., 2014.
Skeletal muscle Exercise Gomez-Cabrera et al., 2005, 2008; Kang et al., 2009; Ristow et al., 2009; Powers et al., 2010;
Strobel et al., 2011; Powers et al., 2011b; Fisher-Wellman et al., 2013; Radak et al., 2013; Ferraro
et al., 2014
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unlike other GPXs, it is not limited to glutathione as a substrate
(Brigelius-Flohe and Maiorino, 2012). Its protein thiols can per-
form the function of GSH, and as a result, GPX4 may function as
either a glutathione peroxidase or a thiol peroxidase adapting to
perform its functions depending on cellular redox conditions.
There are 3 major isoforms of GPX4: cytosolic, mitochondrial
and nuclear (Regev-Rudzki and Pines, 2007). In the mitochon-
dria, GPX4 over-expression has been shown to protect against
cytochrome c release, generation of H2O2 and loss of mem-
brane potential following ischemia/reperfusion injury (Imai et al.,
2003). In diabetic mice, over expression of mitochondrial GPX4
was protective against cardiac ischemia reperfusion injury and
preserves mitochondrial integrity (Chen et al., 2001; Hollander
et al., 2003; Liang et al., 2007; Dabkowski et al., 2008).
Glutathione S-transferase (GST). The GSTs conjugate elec-
trophilic aldehydes with GSH to yield a less reactive conjugate
that is eliminated from the cell by glutathione S-conjugate efflux
pumps, this process not only increases the solubility of conjugated
compounds but marks these structures for elimination from the
cell (Hayes and Pulford, 1995). ROS regulate the expression of
GST via c- fos and c jun signaling (Daniel, 1993). A study in
rat hepatocytes reported that for HNE, metabolism by GST is
responsible for the majority of HNE removal (∼60%); a little is
metabolized by the alcohol and aldehyde dehydrogenases (10%)
leaving∼24% of 4-HNE clearance for other mechanisms (Hartley
et al., 1995).
Aldehyde-metabolizing enzymes:
Aldehyde dehydrogenase. The ALDHs are particularly relevant
in the mitochondria as metabolizers of aldehydes generated
from PUFAs and monoamine oxidase, as it has been demon-
strated that inhibiting ALDH activity has a direct impact on
the metabolism of amines by MAO (Ambroziak and Pietruszko,
1991; Rooke et al., 2000). There are 19 known isoforms of
the ALDH enzyme with ALDH2 as the major mitochondrial
isoform (Marchitti et al., 2008). In human populations, indi-
viduals with a polymorphism for ALDH2 had higher levels of
the biomarker C-reactive protein following myocardial infarction
(Bian et al., 2010). In the SAPPHIRe prospective cohort study,
patients with ALDH2 genetic variants with a possessed two-fold
greater risk of progression to clinical hypertension (Chang et al.,
2012). ALDH3A2 also was found to be important in redox-related
pathologies stemming from nutritional overload. It is expressed
in both the heart and skeletal muscle and displays a substrate
specificity for aldehydes of various long and short chain fatty
acids.
Molybdenum hydroxylases. There are two main enzymes in this
class (1) Aldehyde oxidase (AOX): This enzyme oxidizes alde-
hydes to carboxylic acids and it is relatively nonspecific and its
endogenous role is not well understood. (2) Xanthine Oxidase:
exists as xanthine dehydrogenase-metabolism of aldehydes by
xanthine oxidase generates radicals. These two enzymes share
some amino acid sequence homology and both contain molyb-
denum and iron as well as flavin adenine dinucleotide (FAD) as
co-factors.
Carbonyl reductases. Carbonyl reductases are part of short
chain dehydrogenases/reductases (SDR) family of proteins. These
enzymes are ubiquitous and are largely localized to the cytosol
with some isoforms in the mitochondria and peroxisomes
(Rosemond and Walsh, 2004).
Aldo-ketoreductases. The aldose reductases metabolize lipid alde-
hydes and their glutathione conjugates (Srivastava et al., 2003).
AKR1 specifically metabolizes aldehydes produced by MAO using
NADPH. The mitochondrial isoform accounts for 5% of cell
activity and metabolizes 4-HNE. AKR1B uses both NADH and
NADPH and is also localized in the cytosolic fraction (Srivastava
et al., 1999). It is highly expressed in the cardiovascular sys-
tem, appears to be partly responsible for reducing aldehydes such
as 4-HNE, and its activity is potentiated when the substrate is
conjugated to glutathione.
ROLE OF ROS IN CARDIAC PRECONDITIONING
The role of ROS in cardiac health and disease has become increas-
ingly recognized in research as a part of normal physiology and
pathophysiology due to the multitude of cell regulatory lay-
ers associated with redox biology. Although once thought of as
strictly deleterious to cardiovascular function, the production of
ROS can also elicit an adaptive cardiac preconditioning response.
These beneficial ROS are thought to set in motion signaling
events that can elicit alterations in gene expression, as well as
acute events that can activate proteins in a post-translational
manner. In this regard, several stimuli have been shown to
evoke cardioprotection in a ROS-dependent manner such as
volatile anesthetics, ischemic preconditioning, and pharmaco-
logical compounds. A number of major ROS-mediated cellular
pathways activated in response to these stimuli are illustrated in
Figure 3.
ANESTHETIC PRECONDITIONING
Cardiac preconditioning with volatile anesthetics has received
a considerable amount of attention as a strategy to mitigate
I/R injury through their negative inotropic, anti-arrhythmic and
myocardial infarct salvaging effects (Sahlman et al., 1995; Cope
et al., 1997; Schlack et al., 1997; Lamberts et al., 2009; Riha
et al., 2011; Wojtovich et al., 2011). Several reviews have high-
lighted mechanisms involved in anesthetic-induced cardioprotec-
tion, and ROS have been commonly identified as an important
element to the protective mechanism (Hu and Liu, 2009; Bonney
et al., 2014; Swyers et al., 2014). ROS are known to be intricately
involved in post-ischemic myocardial dysfunction and infarc-
tion, and a reduction in oxidative stress has been identified as an
important component in alleviating I/R injury; (Hamilton et al.,
2004; Dabkowski et al., 2008). Paradoxically, transient bursts of
ROS during anesthetic treatment plays an important role in the
cardioprotective response (Mullenheim et al., 2002; Novalija et al.,
2002; Tanaka et al., 2003). In line with these concepts, treatment
with isoflurane (Tanaka et al., 2002, 2003) or sevoflurane (Kevin
et al., 2003b) increases ROS production during preconditioning,
and reduces oxidative stress during I/R (Nakamura et al., 1999;
Kevin et al., 2003b). Following anesthetic exposure, an increase
in intracellular superoxide production can be detected by the
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FIGURE 3 | Pre-conditioning and ROS-mediated effects in striated
muscle. Shown is a schematic illustrating the development of ROS-mediated
adaptations from various preconditioning paradigms as described in the text.
Adaptive responses that lead to preconditioning in cardiac muscle culminate
in protection through early post-translational modifications to redox sensitive
enzymes, and late adaptations through enhanced translocation of key
transcription factors. The ensuing adaptations result in the early- and
late-window of preconditioning that have been described in the
cardioprotection literature. (ROS, Reactive oxygen species; NOX,
NADPH-oxidase; ETS, Electron transport system; MAO, Monoamine oxidase;
Nrf2, NF E2-related factor-2; HIF1α, Hypoxia-inducible factor-1α; Autocoids,
factors secreted from cells with paracrine-like effects).
fluorescence of oxidized dihydroethidium (Tanaka et al., 2002,
2003; Ludwig et al., 2004). This transient ROS burst is impor-
tant for the preconditioning phenotype as antioxidant treatment
negates the beneficial effects. In particular, isoflurane-induced
infarct salvage is abolished when bracketing anesthetic adminis-
tration with intravenous infusion of various antioxidants. These
antioxidants include: N-2-mercaptoproprionyl glycine (MPG),
Mn(III) tetrakis(4-benzoic acid) porphyrine chloride (MnTBAP),
mitotempol, or the glutathione precursor N-acetylcysteine (NAC)
(Mullenheim et al., 2002; Tanaka et al., 2003; Hirata et al., 2011).
Similarly, the infarct salvaging effect of sevoflurane is abolished by
various ROS scavengers such as glutathione, superoxide dismu-
tase, catalase, MPG or MnTBAP (Novalija et al., 2002; Kevin et al.,
2003b; Lamberts et al., 2009). Studies comparing desflurane and
sevoflurane have demonstrated similar mechanisms of protec-
tion during a metabolic insult (Hanouz et al., 2007; Sedlic et al.,
2009). In vitro studies have also corroborated the importance of
ROS in anesthetic preconditioning. One study demonstrated that
human right atrial contraction during hypoxia/reoxygenation was
better preserved following treatment with desflurane and sevoflu-
rane, and the protective benefits were lost with administration of
MPG (Hanouz et al., 2007). Another study demonstrated that
desflurane and sevoflurane protected rat isolated left ventricu-
lar cells against H2O2 induced cell death, and the antioxidant
trolox abolished protection. Interestingly, ROS production by
desflurane was higher than sevoflurane during preconditioning,
and this translated to greater myocyte survival (Sedlic et al.,
2009). Taken together these studies provide a compelling argu-
ment that transient ROS production acts by influencing down-
stream cardioprotective signaling events. The mechanism of ROS
release as a protective stimuli in anesthetic-induced precondi-
tioning has also been linked to the protection observed with
the ischemic preconditioning (IPC) phenomenon, suggesting that
these two regimens have commonalities in their cardioprotec-
tive mechanisms (Swyers et al., 2014). Indeed IPC also has a
strong literature implicating ROS as a triggering mechanism in
cardioprotection.
ISCHEMIC PRECONDITIONING
The discovery of IPC by Murry et al., in 1986 has paved the
way for an ample amount of research dedicated toward unveiling
underlying mechanisms of cardioprotection. IPC is accomplished
through short intermittent bouts of I/R, typically one to five
cycles, that leads to endogenous protection against an ensuing
longer duration ischemia (Murry et al., 1986). Since then, sev-
eral pathways leading to cardioprotection have been proposed,
but a central theme that has been a mainstay in the IPC literature
is that ROS play an intricate role in the cardioprotective signal-
ing mechanisms (Shiomi et al., 2013). The beneficial effects of
IPC include a reduction in myocardial infarction (Murry et al.,
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1986), reperfusion arrhythmias (Shiki and Hearse, 1987), stun-
ning (Bolli et al., 1997), and necrotic and apoptotic cell death
(Nakamura et al., 2000). A beneficial role for ROS in IPC is now
well-established in the protective signaling cascade. Exposure to
a single bout of IPC reduces infarct size, and cardioprotection
is abolished when various free-radical scavengers are adminis-
tered before and/or during IPC (Tanaka et al., 1994; Baines et al.,
1997; Dost et al., 2008; Liu et al., 2008). Findings on the time
frame of ROS production during preconditioning has been equiv-
ocal with evidence that the beneficial ROS are generated during
the ischemic phase (Kevin et al., 2003a), and others showing the
reperfusion phase (Dost et al., 2008). It has been documented by
multiple groups that a significant amount of ROS can be gener-
ated by mitochondria during ischemia (Vanden Hoek et al., 1998;
Becker et al., 1999; Kevin et al., 2003a), which can be blunted
with ETS inhibitors for sites I and III. It is also known that
there are overlapping mechanisms involved in IPC (Xin et al.,
2012). This is evident by studies demonstrating that free-radical
scavengers do not abolish IPC-mediated cardioprotection when
multiple preconditioning cycles are used (Iwamoto et al., 1991).
The preconditioning mechanism is multifactorial (Yang et al.,
2010), so the use of multiple cycles may heighten signaling cas-
cades through other pathways irrespective of ROS. The precise
mechanisms on how IPC-induced ROS mediate cardioprotection
are still debated, and more research is needed to verify spatial and
temporal activation in the cell, as well as end effectors. The use
of pharmacological agents that that mimic IPC in a laboratory
setting may ultimately foster identification of novel therapeutic
approaches.
PHARMACOLOGICAL PRECONDITIONING
There are several pharmacological approaches that have been
shown to mimic the preconditioning phenomenon. Diazoxide
is a potassium channel activator whose cardioprotective char-
acteristics are thought to derive from a ROS preconditioning
stimuli leading to activation of downstream end-effectors (Garlid
et al., 1997; Tritto et al., 1997; Pain et al., 2000; Forbes et al.,
2001). This is supported by studies where the antioxidants MPG
and NAC reduced diazoxide-induced ROS production, and block
the recovery of LVDP following global I/R (Forbes et al., 2001).
Although cardiomyocytes contain both a mitoKATP channel and
a sarcolemmal KATP channel, diazoxide and the potassium chan-
nel blocker 5-Hydroxydecanoate (5-HD) are thought to have
a higher specificity for the mitoKATP channel (Garlid et al.,
1996; Yellon and Downey, 2003). In addition, other potassium
channel openers nicorandil and cromakalim have been shown
to increase superoxide production in isolated hearts, and the
mitoKATP channel blockers 5-HD and glibenclamide decreased
ROS production (Obata and Yamanaka, 2000). Follow up studies
show that nicorandil protects against in vivo I/R injury in rab-
bit hearts; and the mitoKATP channel blocker 5-HD abolished
protection, while blockade of the sarcolemmal KATP channel had
no effect (Das and Sarkar, 2003). Importantly, treatment with
nicorandil during the reperfusion period did not provide pro-
tection, which supports the idea that apriori ROS are setting the
stage as a trigger for protective signaling cascades. Others stud-
ies investigating the cardioprotective mechanism of acetylcholine
and bradykinin demonstrate that an increase in ROS produc-
tion during treatment is a central component to their infarct
sparing effects because the antioxidant MPG abolishes protection
(Cohen et al., 2001; Krieg et al., 2004). The authors concluded
that agents signaling through Gi proteins share common pre-
conditioning pathways, but adenosine induced protection diverts
from this hypothesis, because an adenosine receptor agonist co-
administered with MPG or 5-HD did not abolish protection
(Cohen et al., 2001). Although adenosine receptor activation
can reduce infarct size irrespective of ROS signaling, the down-
stream preconditioning cascade may be similar in regard to
intermediate signaling through mitoKATP channels (Miura et al.,
2000). Statin treatment has also been implicated in cardioprotec-
tion through the upregulation of ROS production by mitoKATP
channel activation. The improved post-ischemic contractile func-
tion observed with parvastatin was abolished with NAC and
5-HD. The authors concluded that parvastatin leads to the acti-
vation of mitoKATP channels and that downstream activation of
PKC mediates the protective phenotype. However, the order of
events in this signaling cascade is still under investigation. Mild
mitochondrial uncoupling has also been implicated as a precon-
ditioning mechanism, although irrespective of mitoKATP channel
activation (Holmuhamedov et al., 1999). Support for a role of
ROS release during uncoupling comes from studies where low
concentrations of p-(trifluoromethoxy)phenylhydrazone (FCCP)
improved post-ischemic mechanical function. These studies
demonstrate that FCCP increased ROS independent of mitoKATP
channel activation. Importantly protection was lost with antiox-
idant administration, but not with mitoKATP channel blockers
(Brennan et al., 2006). Caveats to studies implicating mitoKATP
channels in preconditioning are the use of diazoxide and 5-HD,
which has been shown to have non-specific effects (Hanley et al.,
2003; Drose et al., 2006; Li et al., 2010). In addition, there is still
uncertainty as to the function and existence of mitoKATP channels
due to the elusiveness of their molecular composition (reviewed
in Szabo and Zoratti, 2014). A recent study using a compre-
hensive proteomics analysis of mitochondrial inner membrane
proteins combined with RNA knockdown technique suggested
that KCNJ1-encoded renal outer medullary potassium channel
(ROMK) is a critical pore-forming subunit of the mitoKATP
channel (Foster et al., 2012). Clearly, more studies using tar-
geted molecular approaches such as this are needed to pre-
cisely identify all components of this potentially very important
channel.
SOURCES OF ROS: WHERE DO THEY COME FROM?
Many of the preconditioning studies reviewed thus far suggest
that beneficial ROS production from various stimuli are mito-
chondrial in origin (Baines et al., 1997; Vanden Hoek et al., 1998;
Das et al., 1999; Cohen et al., 2001; Tanaka et al., 2002; Andrukhiv
et al., 2006; Sedlic et al., 2009). There has been an ample amount
of research showing that the opening of mitochondrial chan-
nels/pores and fluctuations in mitochondrial membrane potential
leads to the release of ROS (O’Rourke et al., 2007; Aon et al., 2010;
Brown and O’Rourke, 2010; Gauthier et al., 2013), but whether
channel/pore opening acts as a trigger vs. a mediator of cardio-
protection is still being debated. While it is known that ROS are
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a commonality to IPC, controversy exists as to when the ROS
are released. In isolated chick cardiomyocytes exposed to hypoxic
preconditioning an increase in ROS production was observed
during the hypoxic period that is abrogated with the complex III
inhibitor myxothiazol, but not a NOX or NOS inhibitor (Vanden
Hoek et al., 1998). Although ROS have been shown to be released
during the ischemic cycle of IPC (Vanden Hoek et al., 1998; Kevin
et al., 2003a), Dost et al. propose that ROS generated during
the reperfusion phase are providing the redox signals for car-
dioprotection because MPG administered during the ischemic
cycle did not abolish the infarct salvaging effect of IPC (Dost
et al., 2008). More recent studies implicate mitochondrial derived
ROS, nitric oxide, and the mitochondria redox state as possi-
ble regulators of mitoKATP channel opening in IPC-mediated
cardioprotection (Queliconi et al., 2011). Pharmacological acti-
vation of the mitoKATP channel is presumed to proceed in a
similar manner to that of IPC, however, as mentioned previ-
ously, the relationship between PKC activation, ROS production,
and mitoKATP channel activation is still being investigated (Tritto
et al., 1997; Pain et al., 2000; Liu et al., 2008; Yang et al., 2010). The
mechanism of ROS release following mitoKATP channel opening
is thought to occur due to mitochondrial uptake of potassium
leading to slight alkalization and mild uncoupling (Andrukhiv
et al., 2006), however the precise mechanism is unknown. Further
evidence using the mitoKATP channel openers diazoxide or cro-
makalim suggests that ROS are derived from site I of the ETS
because rotenone did not have an effect on myxothiazol-induced
ROS production (Andrukhiv et al., 2006). Also, complex III of
the ETS has been shown to generate ROS during IPC (Vanden
Hoek et al., 1998); and similar findings were reported when
mitoKATP channels were activated through bradykinin-induced
preconditioning (Oldenburg et al., 2004). Furthermore, com-
plex III generated ROS appear to also mediate preconditioning
with isoflurane because myxothiazol treatment abolished the
ROS burst as well as the infarct salvaging effects of isoflurane
(Ludwig et al., 2004). Taken together, these findings suggest
that mitochondrial derived ROS, particularly from the ETS, are
responsible for a large portion of ROS release in models of pre-
conditioning. This further supports the idea of an optimal “zone”
where ROS release results in favorable adaptions, whereas exacer-
bated ROS release can lead to maladaptive responses in diseased
states.
END-EFFECTOR MECHANISMS: WHAT LEADS TO PROTECTION?
If ROS are a playing a substantial role in cardioprotection the
question becomes, what are the end-effector mechanisms? In
models of IPC there are several hypothesis implicating ROS as a
means to an end-effector response. An increase in ROS produc-
tion during IPC is proposed to activate an inner mitochondrial
PKC-ε that phosphorylates and inhibits mitochondrial perme-
ability transition (Costa et al., 2006; Costa and Garlid, 2008). A
higher threshold for mitochondrial permeability transition fol-
lowing IPC has been demonstrated by several groups and is
thought to be one of the mechanisms by which IPC reduces I/R
injury (Argaud et al., 2004; Costa et al., 2006; Clarke et al., 2008).
Studies have shown that PKC-ε interacts with mitochondrial pro-
teins that constitute the transition pore, and that PKC-ε can
phosphorylate the mitochondrial voltage-dependent anion chan-
nel (VDAC) in vitro (Baines et al., 2003). However, others have
failed to observe a change in phosphorylation of mitochondrial
permeability transition pore components following IPC (Clarke
et al., 2008). This study did observe that IPC inhibited mito-
chondria permeability transition, but attributed it to a reduction
in oxidative stress during I/R injury; although they did not rule
out PKC-ε as part of the protective signaling mechanism. Further
support for the importance of PKC is provided by studies demon-
strating that preconditioning with diazoxide can be blocked when
the PKC inhibitor chelerythrine is administered either before dia-
zoxide pretreatment or 10 min before I/R (Takashi et al., 1999),
suggesting that the activation of a PKC-ε isoform is playing a
downstream role in this form of cardioprotection. However, oth-
ers hypothesize that PKC activation during IPC sensitizes the
myocardium to adenosine, leading to the activation of reperfu-
sion injury salvage kinases such as Akt and ERK (Kuno et al., 2008;
Yang et al., 2010).
EXERCISE-DEPENDENT ADAPTATIONS EVOKED BY ROS
The relationship between an active lifestyle through physical
activity/exercise with increased longevity and decreased mortal-
ity is well known (Hamalainen et al., 1995; Lee et al., 2012a).
Although there are numerous adaptive responses following
exercise, adaptations at the cellular level present as an increase
in skeletal muscle mitochondrial content, which is a hallmark
of aerobic exercise training and increased endurance capacity.
It has been demonstrated that ROS production is important
for this hormetic effect of exercise (Kang et al., 2009), and
that co-administration of antioxidants may abolish some of the
observed health benefits (Ristow et al., 2009). Therefore, it is of
interest to determine what and how adaptations are evoked by
exercise-induced ROS.
SOURCES OF ROS DURING EXERCISE
Mechanical loading of cardiac (Sanchez et al., 2008; Prosser
et al., 2011) and skeletal (Ihlemann et al., 1999; Chambers
et al., 2009) muscle during contraction/relaxation has been impli-
cated as a mechanism by which ROS signaling can evoke adap-
tive responses. Mechanical stretch of mouse extensor digitorum
longus (EDL) muscle increases ROS production and promotes
enhanced glucose uptake, independent of insulin signaling, and
this is abolished with various ROS scavengers (Chambers et al.,
2009). An increase in skeletal muscle ROS production during
stretch and contraction is evidenced by increases in the fluo-
rescence of the H2O2 sensitive probe, CM-H2 DCF (Sandstrom
et al., 2006; Chambers et al., 2009) and GSSG:GSHT levels
(Sandstrom et al., 2006), neither of which was observed in
the presence of the antioxidant NAC. In line with the idea
that intracellular ROS production can influence surrounding
tissue, one study demonstrated that local ROS production by
contracting skeletal muscle may provide a signal to increase
the tissue repair response following exercise. NOX-generated
H2O2 can facilitate the recruitment of neutrophils to skele-
tal muscle tissue following intense exercise (Nunes-Silva et al.,
2014). The manner by which H2O2 produced this response was
through increased intracellular adhesion molecule expression
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leading to enhanced leukocyte-endothelial interaction within
the muscular micovasculature endothelial cells. These findings
raise the question as to the locus of ROS production, skele-
tal muscle vs. vascular, since both tissues are known expressers
of the NOX2 isoform (Frey et al., 2009; Barbieri and Sestili,
2012).
A similar role for NOX2 in cardiac tissue has been demon-
strated whereby myocardial stretch and tachycardia increases
NOX2 generated ROS leading to redox modification of the ryan-
odine receptor and increased calcium spark frequency (Sanchez
et al., 2008; Prosser et al., 2011). Further implications for NOX2
derived ROS in cardiac adaptations to exercise was demonstrated
by our laboratory, where inhibition of NOX2 abolished the infarct
salvage effect of exercise in rats (Frasier et al., 2013). Indeed
other sources of ROS production may be mediating adaptations
to exercise as well. Some studies suggest that complex I generated
ROS and subsequent release into the cytosol through mitoKATP
channels can evoke cardioprotection (Domenech et al., 2002;
Andrukhiv et al., 2006), but the evidence for this as a mechanism
of ROS production during exercise is scarce. The phospholipase
A2-lipoxygenase pathway has been shown to release ROS into the
extracellular space in rat skeletal muscle preps, although the phys-
iological implications for this have not been determined (Zuo
et al., 2004). Another factor to take into consideration is the
degree and spatial production of ROS as a function of exercise
intensity.
During high intensity/exhaustive exercise the production of
ROS by xanthine oxidase (XO) appears to increase plasma
biomarkers oxidative stress (Vina et al., 2000). An increase in
plasma XO activity was shown to be important for the activation
of adaptive responses to exercise in skeletal muscle (Gomez-
Cabrera et al., 2005), because inhibition of XO with allopurinol
prevented the activation of MAPKs and abolished the increase
in MnSOD gene expression associated with exercise. However,
whether or not these effects were due to ROS generated in the
plasma vs. the cytoplasm cannot be inferred. Allopurinol may
instead be inhibiting the production of intracellular ROS and pre-
venting activation of redox sensitive pathways, which has been
shown to be the case for the activation of PGC-1α following acute
exercise (Kang et al., 2009). The role of XO on ROS production
has been shown to be miniscule in other studies, where allopuri-
nol did not mitigate ROS production as assessed by GSSG lev-
els. Moreover, XO inhibition did not attenuate exercise-induced
mitochondrial biogenesis and antioxidant gene expression with
chronic exercise (Wadley et al., 2013), indicating that other ROS
producing enzymes may be more important for these adaptations
to exercise.
With respect to LPPs formed during exercise, measurements
of protein carbonylation have yielded surprising and even con-
tradictory results. One recent study reported that chronic exercise
in middle aged human male subjects resulted in increased uri-
nary levels of 8-hydroxy-2′-deoxyguanosine (8-OHdG), 4-HNE
carbonyl adducts, and immune system activation, indicative of
a greater level of protein carbonylation (Sasaki et al., 2013).
However, another study showed that protein carbonylation was
decreased in skeletal muscle of rats following an acute bout
of swimming (Magherini et al., 2013). This suggests that LPP
formation and subsequent protein carbonylation following exer-
cise is complex, and there may be differences in compartmental-
ization into blood, muscle, and other organs, in addition to time-
dependent factors and type of exercise (i.e., acute vs. chronic)
to consider. In any case, these findings illustrate the need for a
more detailed investigation of the mechanisms and role of LPPs
in exercise.
MECHANISMS RESPONSIBLE FOR ROS-DEPENDENT ADAPTATIONS TO
EXERCISE
It is now commonly accepted that ROS have both beneficial and
detrimental effects on the cell depending on the delicate balance
between scavenging and production. There are several fates of
ROS that typically play out in a finite span of time due to their
relatively short half-life. While it was originally thought that exer-
cising muscle produces ROS that could be detrimental to the
cell through the oxidation of macromolecules, the paradigm has
shifted over the last several years. However, the mechanism by
which ROS exert beneficial cellular adaptations has been hard
to identify, and is an area of research that is dynamically evolv-
ing. In addition, the production of ROS, or ROS byproducts,
by exercising muscle may lead to direct or indirect alterations
to the vasculature, or other organs, in an endocrine like man-
ner. However, whether or not exercise-induced adaptations arise
from ROS endocrine-like signaling has not been established. In
the literature, there are discrepant findings for changes in blood
markers of ROS production following different exercise intensi-
ties. Recently Bloomer’s group did not observe changes in blood
H2O2, malondialdehyde (MDA), or advanced-oxidation protein
products immediately after an acute aerobic or high intensity
exercise bout in trained men (Bloomer et al., 2005). Similar results
have been demonstrated after acute exercise in regard to changes
in MDA, although elevated levels of ROS were evident post-
exercise as measured by electron spin resonance spectroscopy and
an increase in the ratio of oxidized glutathione to total glutathione
(GSSG:GSHT) (Groussard et al., 2003; Bloomer et al., 2005).
These discrepant findings have several implications when taken
together: (1) changes in circulating oxidative stress biomarkers
may not be indicative of intracellular ROS production; (2) some
assays may not be sensitive enough to detect ROS biomarkers;
or (3) circulating antioxidant capacity is sufficient to handle the
oxidative burden if ROS do get into circulation. While ROS may
play an integral role in overall adaptations to exercise, these stud-
ies suggest that the beneficial effects of ROS on muscle may
be more local rather than exerting a direct effect on systemic
adaptations.
Exercise sets in motion adaptive signaling partly through cel-
lular ROS acting as second messengers to alter redox sensitive
enzymes (Sadoshima, 2006). Following exercise the cellular redox
status transitions toward a more oxidized environment, leading
to the activation of endogenous protective mechanisms (Frasier
et al., 2011a, 2013). The ROS generated during exercise likely play
a major role in the upregulation of antioxidant defense mecha-
nisms, as evidenced by the increase in GR that results after acute
exercise. Importantly this up-regulation is abrogated in cardiac
muscle when NOX2-generated ROS are blocked prior to exer-
cise (Frasier et al., 2013). ROS also play an important component
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in the nuclear translocation of Nrf2 and its binding activity
as a transcription factor in cardiac muscle. The importance of
this response following 2 days of exercise is demonstrated in
Nrf2 knockout mice that display an exacerbated oxidative stress
response to exercise with a decrease in key antioxidant enzymes
and precursors (Muthusamy et al., 2012). Similarly, in skeletal
muscle ROS appear to be important for the activation of tran-
scription factors for mitochondrial biogenesis, as daily vitamin C
and E supplementation negated the increase in cytochrome c oxi-
dase subunit IV and PGC-1α following 11 weeks of endurance
training in humans (Richters et al., 2011). Further support for
in vivo local ROS production by the exercising skeletal muscle
has been provided by microdialysate samples that were analyzed
for cytochrome c reduction as a marker of superoxide produc-
tion (Hellsten et al., 2007). It has also been shown that skeletal
muscle produced ROS may facilitate angiogenesis and increased
capillary density through enhanced VEGF production (Kosmidou
et al., 2001), but in vivo findings with antioxidant supplementa-
tion indicate that ROS may not be an important component to
the VEGF response from exercise (Hellsten et al., 2007). Evidence
for direct ROS-mediated adaptations is difficult pin down due
to their promiscuous nature, but the aftermath of an increased
oxidized environment is a tell-tale sign of ROS-mediated effects.
These studies provide strong evidence for a direct effect of ROS on
the enhanced antioxidant response to exercise and indicate this as
one of the primary adaptive signaling events in both cardiac and
skeletal muscle.
COMPENSATORY CHANGES IN ENDOGENOUS ANTIOXIDANT
DEFENSES AND OXIDATIVE PHOSPHORYLATION CAPACITY
In regard to adaptations, ROS production during exercise may act
as a prophylactic in the mitigation of a greater oxidative stress,
as in myocardial ischemia/reperfusion injury, or skeletal muscle
oxidative stress during nutrient overload. It is well documented
in the exercise cardioprotection literature that acute exercise
improves the redox buffering capacity of the cell as evidenced by
an increase in redox specific enzymes such as glutathione reduc-
tase (GR), thioredoxin reductase, and MnSOD (Yamashita et al.,
1999; Frasier et al., 2011b, 2013; Lee et al., 2012b; Fisher-Wellman
et al., 2013). Changes in the activity of H2O2 scavenging systems
are less robust in the response to exercise, with most studies find-
ing little to no difference in glutathione peroxidase, catalase, and
thioredoxin (Frasier et al., 2011a). An enhanced ability to cope
with an oxidative stress of greater magnitude is responsible for
a large portion of the exercise-induced adaptations afforded by
exercise. Several studies have demonstrated that when antioxi-
dants are administered prior to exercise, the protection against
myocardial infarction and maintenance of mechanical function
following I/R are lost (Yamashita et al., 1999; Akita et al., 2007;
Nelson et al., 2011). This implies that ROS are acting through
redox circuits during an exercise bout to modify the cellular
response to that stressor; and without this signal, some adapta-
tions are lost. However, the locus of ROS production for cardiac
adaptions to exercise is still under investigation. We recently
found that cytoplasmic ROS generated by NOX2 increases GR
activity through post-translational modifications, and the NOX2
inhibitor apocynin abolished the increase in activity immediately
after, and 24 h after exercise. While not all studies have shown
ROS to be a requirement for cardioprotection (Taylor and Starnes,
2012), it is hard to refute the evidence that there are beneficial
ROS that can lead to favorable adaptions.
It is well known that exercise training increases skeletal mus-
cle mitochondrial density, with a subsequent increase in aerobic
capacity. But of equal importance is the quality and oxida-
tive phosphorylation capacity of individual mitochondrion. Rats
bred for high-capacity running have increased maximal ADP-
stimulated respiration and greater complex IV capacity compared
to rats bred for low-capacity running (Tweedie et al., 2011).
Although the high-capacity runners have higher basal rates of
H2O2 emission in soleus muscle, they also exhibit a compensatory
increase in SOD activity. Furthermore, they had lower DNA dam-
age as assessed by 8-OHdG. These findings are important as a clue
to skeletal muscle adaptations to exercise, as enhanced exercise
capacity is linked with a favorable compensation to ROS scaveng-
ing. Enhanced respiratory capacity as an adaptation to exercise
permits cellular energetics to be better maintained, with fewer
limitations on the system, and findings in permeabilized fibers
from sedentary humans undergoing endurance and strength
training programs support this as well. Following endurance and
strength training, oxidative phosphorylation capacity increases
with the greatest shift in capacity arising from fatty acid oxidation
(Pesta et al., 2011). Similar to skeletal muscle, enhancements in
cardiac mitochondrial phosphorylation capacity and efficiency
was demonstrated in a mouse model of diet-induced obesity and
exercise. Isolated cardiac mitochondria from mice exposed to a
high-fat diet and 8–10 weeks of high-intensity interval training
displayed higher maximal respiratory capacity and ADP phos-
phorylation to oxygen consumption (P/O) ratios (Hafstad et al.,
2013) compared to sedentary counterparts. Importantly, these
adaptations resulted in significant improvements in LV function
and reductions in myocardial fibrosis. We have also observed
compensatory responses to the antioxidant network from exer-
cise and high calorie diets in heart and skeletal muscle, whereby
thioredoxin reductase-2 plays an important role in modulating
the levels H2O2 produced during fatty acid oxidation (Fisher-
Wellman et al., 2013). Insight from these studies demonstrates
that mitochondrial adaptations/maladaptations are involved in
the etiology of cardiometabolic abnormalities, and antioxidant
defense mechanisms and respiratory capacity play an important
component in affected tissues. In combination, adaptations to
these components allows for tighter regulation of redox- and
energy-homeostasis during episodes of increased oxidative stress
that is encountered with disease pathology.
RECONCILING THE PARADOX: THE ROAD AHEAD
The mechanisms underlying this contrast in outcomes between
therapeutically-induced and disease-induced oxidative stress are
not clear, as differences in source of ROS, sub-cellular and tis-
sue compartmentalization, temporality of ROS production (i.e.,
pulsatile vs. constitutive), and transcriptional response path-
ways are all likely involved to some extent. Specific pathways
that have been shown to be involved in mediating the adaptive
responses to oxidative stress in striated muscle include activa-
tion of ROS scavenging networks, increases in mitochondrial
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biogenesis/respiratory capacity, and activation of cell quality con-
trol systems (e.g., autophagy/mitophagy). When oxidative stress
is prolonged or of high enough magnitude in disease settings, the
myocyte still responds in a controlled manner; only this response
is a result of a highly oxidized environment that clearly results
in a maladaptive phenotype. Overwhelming levels of oxidative
stress in disease states leads to alterations in myocyte mitochon-
drial function and polarity, cell death, and hyper-activation of
neutrophils/macrophages with subsequent fibrosis.
Unfortunately the contrast between beneficial ROS and mal-
adaptive ROS may not be as clear cut as originally thought due
to the complexity of regulation in biological redox signaling.
From a therapeutic standpoint, this ambiguity makes it very dif-
ficult to implement antioxidant therapies in the clinic, as there
is now very compelling evidence that antioxidants exert nega-
tive effects under certain physiological contexts, and in some
cases may actually do more harm than good (Ristow, 2014).
Moreover, it is now clear that a fine regulation of redox signaling
is layered on top of gene regulation and extracellular-regulated
responses to oxidative stress. For example, recent findings con-
cerning the role of “mitohormesis” in maintaining homeostasis,
particularly under various contexts of nutrient deprivation and
overload, serve to add another layer of complexity to the role
of redox signaling in the cell (Ristow and Schmeisser, 2014; Yun
and Finkel, 2014). Never-the-less, these complexities only serve
to underscore the importance of understanding how cellular net-
works respond to oxidative challenges. If we are to move forward
in our comprehension of these networks then there has to be a
more rigorous evaluation of the specific intra/intercellular sys-
tems that are evoked by ROS, and the key signaling events that are
involved. Steps in this direction will further our understanding as
to what controls the switch in response to beneficial vs. harmful
oxidative stress. Uncovering these regulatory control nodes may 1
day lead to advances that allow us to remain in the Goldilocks
Zone en route to dampening the burden of cardio-metabolic
disease.
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